Kentucky Cancer Registry Spring Training 2017

Similar documents
Instructions for Coding Grade for 2014+

Kyle L. Ziegler, CTR. California Cancer Registry U.C. Davis Health System

WHAT S NEW: JANUARY-FEBRUARY 14 FROM THE COC-SEER-NPCR TECHNICAL WORKING GROUP

2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018

7/29/ Grade Coding Instructions ICD-O-3 Updates. Outline. Introduction to Coding Grade for 2014+

2018 New Grade Coding Rules It s a Good Thing!

MCR: MANAGEMENT OF 2018 CHANGES. By: Maricarmen Traverso-Ortiz MPH, CGG, CTR

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines

DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

CODING TUMOUR MORPHOLOGY. Otto Visser

Format Of ICD-O Terms In Numerical List Each topographic and morphologic term appears only once The first listed term in Bold Type is the Preferred Te

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I

Collaborative Staging

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Outline. How to Use the AJCC Cancer Staging Manual, 7 th ed. 7/9/2015 FCDS ANNUAL CONFERENCE ST PETERSBURG, FLORIDA JULY 30, 2015.

Interactive Staging Bee

ICD-O CODING Third Edition

Genitourinary. Presentation Outline. Genitourinary System 12/14/2011. FCDS 2011 Educational Webcast Series December 15, 2011

CS Evaluation Fields. Outline of Presentation. Purpose of Evaluation Field. CSv2 Title of Presentation Jan 2011 Lecture Version: 1.

Quiz. b. 4 High grade c. 9 Unknown

Colon and Rectum: 2018 Solid Tumor Rules

A Practicum Approach to CS: GU Prostate, Testis, Bladder, Kidney, Renal Pelvis. Jennifer Ruhl, RHIT, CCS, CTR Janet Stengel, RHIA, CTR

NAACCR Webinar Series 1

NAACCR Grade 2018 Q & A

FINALIZED SEER SINQ QUESTIONS April July, 2017

List of Available TMAs in the PRN

Kidney Q&A 5/5/16 Q1: Can we please get that clarification sent with the presentation and Q&A? Also a start date for that clarification

Collecting Cancer Data: Breast. Prizes! Collecting Cancer Data: Breast 8/4/ NAACCR Webinar Series 1. NAACCR Webinar Series

COLON AND RECTUM SOLID TUMOR RULES ABSTRACTORS TRAINING

2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018?

Kidney, Bladder and Prostate Neoplasia. David Bingham MD

Prostate Overview Quiz

Tumor Comparison. NAACCR Death Clearance Manual Update. Bobbi Jo Matt, BS RHIT CTR NAACCR 2013 Conference, Austin, TX June 12, 2013

Introduction & Descriptors

2007 New Data Items. Slide 1. In this presentation we will discuss five new data items that were introduced with the 2007 MPH Coding Rules.

AJCC 8 th Edition Staging. Introduction & Descriptors. Learning Objectives. This webinar is sponsored by

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

AJCC 8 th Edition Staging. Introduction & Descriptors. Learning Objectives. This webinar is sponsored by

Quality ID #250 (NQF 1853): Radical Prostatectomy Pathology Reporting National Quality Strategy Domain: Effective Clinical Care

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

CASEFINDING. KCR Abstractor s Training

Introduction to ICD-O-3 coding rules

Change Log V1.3- v1.4

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I

The European Commission s science and knowledge service. Joint Research Centre

AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM?

Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast

FINALIZED SEER SINQ QUESTIONS

SEER Summary Stage Still Here!

SEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

SEER Appendix C: Site Specific Coding Guidelines

Measure #250 (NQF 1853): Radical Prostatectomy Pathology Reporting National Quality Strategy Domain: Effective Clincial Care

Quiz 1. Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios.

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

came from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary

5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry

Vivien W. Chen, PhD Mei-Chin Hsieh, MSPH, CTR Lisa A. Pareti, BS, CTR Xiao-Cheng Wu, MD, MPH, CTR. NAACCR Conference Portland, Oregon, June 5-7, 2012

NAACCR Webinar 2018 SeriesImplementations and Timelines

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False

2018 Updates to National Standards

Pathology Mystery and Surprise

FORDS. Facility Oncology Registry Data Standards Revised for 2010 (Incorporates all updates since originally published in July 2002)

What s New for 8 th Edition

NPQR Quality Payment Program (QPP) Measures 21_18247_LS.

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

NEW JERSEY STATE CANCER REGISTRY

Cerebral Parenchymal Lesions: I. Metastatic Neoplasms

Other Sites. Table 2 Continued. MPH Rules 11/8/07. NAACCR Webinar Series 1

Boot Camp Case Scenarios

Testicular Malignancies /8/15

Comparative Analysis of Stage and Other Prognostic Factors Among Urethral, Ureteral, and Renal Pelvis Malignant Tumors

Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ]

2010 Update. NAACCR Webinar Series 1 4/1/2010. Agenda. Access to 2010 Information. CSv2. Collecting Cancer Data: Soft Tissue Sarcoma

Shore Medical Center Site-Specific Study: Colorectal Cancer 2013

Collecting Cancer Data: Prostate Q&A. Overview. NAACCR Webinar Series June 11, 2009

VISUAL EDITING GUIDELINES March 2015 (revised June 2015)

2018 Summary Stage PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

Interactive Discussion of Part I CS Coding Instructions: Working the Cases

Data Quality Analysis of Prostate Cancer Site Specific Factors in Metropolitan Detroit SEER Data,

Neoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture

NPCR s TNM Stage Calculator

ONCOLOGY. Csaba Bödör. Department of Pathology and Experimental Cancer Research november 19., ÁOK, III.

Urology An introduction to cut up DR J R GOEPEL

Prostate Case Scenario 1

Evaluation of Abstracting: Cancers Diagnosed in MCSS Quality Control Report 2005:2. Elaine N. Collins, M.A., R.H.I.A., C.T.R

Coding Pitfalls 9/1/2011. Coding Pitfalls Questions. Fabulous Prizes!!! September 1, NAACCR Webinar Series 1

Updates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency

Staging for Residents, Nurses, and Multidisciplinary Health Care Team

Q: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done.

Coding Pitfalls 9/11/14

1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ 2 Primary Site (291) = C711 Date of Diagnosis (283) =

Q&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012

3. Guidelines for Reporting Bladder Cancer, Prostate Cancer and Renal Tumours

WHAT S NEW: MAY/JUNE REGISTRATION ONLINE: register.pl

Transcription:

Kentucky Cancer Registry Spring Training 2017

What we will cover Coding instructions for grade Case examples addressing some areas of confusion for grade New grade data items coming in 2018 TNM

Where to find Grade coding instructions? https://seer.cancer.gov/tools /grade/grade-2014-codinginstructions.pdf

Grade instructions 1-2 Read you instructions and keep them handy at all times. 1. Systemic treatment and radiation can alter a tumor s grade. Therefore, it is important to code grade based on information prior to neoadjuvant therapy even if grade is unknown. 2. Code the grade from the primary tumor only. Do NOT code grade based on metastatic tumor or recurrence. In the rare instance that tumor tissue extends contiguously to an adjacent site and tissue from the primary site is not available, code grade from the contiguous site. If primary site is unknown, code grade to 9.

Grade instruction 3 3. Code the grade shown below (6th digit) for specific histologic terms that imply a grade. Carcinoma, undifferentiated (8020/34) Carcinoma, anaplastic (8021/34) Follicular adenocarcinoma, well differentiated (8331/31) Thymic carcinoma, well differentiated (8585/31) Sertoli-Leydig cell tumor, poorly differentiated (8631/33) Sertoli-Leydig cell tumor, poorly differentiated with heterologous elements (8634/33) Undifferentiated sarcoma (8805/34) Liposarcoma, well differentiated (8851/31) Seminoma, anaplastic (9062/34) Malignant teratoma, undifferentiated (9082/34) Malignant teratoma, intermediate type (9083/32) Intraosseous osteosarcoma, well differentiated (9187/31) Astrocytoma, anaplastic (9401/34) Oligodendroglioma, anaplastic (9451/34) Retinoblastoma, differentiated (9511/31) Retinoblastoma, undifferentiated (9512/34)

Grade instruction 4a-4b 4a. Make sure to code the grade of the malignancy Do not code dysplasia grade Example high grade dysplasia (CIN III) Code the grade for an in situ tumor if the grade is given 4b. If there are both in situ and invasive components, code only the grade for the invasive portion even if its grade is unknown.

Grade instruction 5 5. If there is more than one grade, code the highest grade within the applicable system. Code the highest grade even if it is only a focus. Code grade in the following priority order using the first applicable system: Special grade systems for the sites listed in Coding for Solid Tumors #6 Differentiation: use Coding for Solid Tumors #7: 2-, 3-, or 4- grade system Nuclear grade: use Coding for Solid Tumors #7: 2-, 3-, or 4- grade system If it isn t clear whether it is a differentiation or nuclear grade and a 2-, 3-, or 4- grade system was used, code the specific grade. Terminology (use Coding for Solid Tumors #8)

Grade instruction 6 6. Use the information from the special grade systems first. If no special grade can be coded, continue with Coding for Solid Tumors #7-9. Special grade systems for solid tumors CS Schema Breast Prostate Special Grade System Nottingham or Bloom-Richardson (BR) Score/Grade (SSF7) Gleason's Score on Needle Core Biopsy/Transurethral Resection of Prostate (TURP) (SSF 8) Prostate Gleason's Score on Prostatectomy/Autopsy (SSF 10) Heart, Mediastinum Grade for Sarcomas (SSF 1) Peritoneum Grade for Sarcomas (SSF 1) Retroperitoneum Grade for Sarcomas (SSF 1) Soft Tissue Grade for Sarcomas (SSF 1) Kidney Parenchyma Fuhrman Nuclear Grade (SSF 6)

Grade instruction 7 7. Use the Two-, Three- or Four-grade system information If you have any confusion on what grading system is being used you should refer to the pathologist directly or cancer committee or cancer conferences to ask the pathologist to confirm/verify. Two-grade system Term Description Grade Code 1/2, I/II Low grade 2 1 2/2, II/II High grade 4 3 Exception for Breast and Prostate Grade Code In transitional cell carcinoma for bladder, the terminology high grade TCC and low grade TCC are coded in the two-grade system.

Grade instruction 7 continued 7. Use the Two-, Three- or Four-grade system information Three-grade system Term Description Grade Code 1/3 Low grade 2 1 2/3 Intermediate grade 3 2 3/3 High grade 4 3 Exception for Breast and Prostate Grade Code

Grade instruction 7 continued 7. Use the Two-, Three- or Four-grade system information Four-grade system Term Description Grade Code 1/4 Grade I; Well differentiated 1 2/4 Grade II; Moderately differentiated 2 3/4 Grade III; Poorly differentiated 3 4/4 Grade IV; Undifferentiated 4

Grade instruction 8 8. Terminology: use the Description column or the Grade column to code grade. Breast & Prostate use the same grade code with a few noted exceptions. Description Grade Assigned Grade Code Exception for Breast and Prostate Grade Code Differentiated, NOS I 1 Well differentiated I 1 Only stated as Grade I I 1 Fairly well differentiated II 2 Intermediate differentiation II 2 Low grade I-II 2 1 Mid differentiated II 2 Moderately differentiated II 2 Moderately well differentiated II 2 Partially differentiated II 2 Partially well differentiated I-II 2 1 Relatively or generally well differentiated II 2 Only stated as Grade II II 2

Grade instruction 8 continued Description Grade Assigned Grade Code Exception for Breast and Prostate Grade Code Medium grade, intermediate grade II-III 3 2 Moderately poorly differentiated III 3 Moderately undifferentiated III 3 Poorly differentiated III 3 Relatively poorly differentiated III 3 Relatively undifferentiated III 3 Slightly differentiated III 3 Dedifferentiated III 3 Only stated as Grade III III 3 High grade III-IV 4 3 Undifferentiated, anaplastic, not differentiated IV 4 Only stated as Grade IV IV 4 Non-high grade 9

Grade instruction 9 9. If no description fits or grade is unknown prior to neoadjuvant therapy, code as a 9 (unknown).

Grade Examples Example 1 Example 2 Example 3 Example 4 Example 5 Example 6

New Grade Data Items in 2018 AJCC Grade Clinical To be used when assigning AJCC clinical stage AJCC Grade Pathologic To be used when assigning AJCC Pathologic stage

TNM Staging The most important thing to remember is to open your manuals for each case Is the histology included in the chapter? Are the criteria for staging being met? Clinical staging requires that the cancer was known or suspected Pathologic must meet the resection criteria

Questions?